Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

14 nov 2024 7:30 a.m. - 15 nov 2024 4:10 p.m.

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 2, Track A: Health Canada and International Collaboration Initiatives

Session Chair(s)

My  Dang, MBA

My Dang, MBA

Director/Consultant, Regulatory Affairs

Cencora, Canada

The drive to bring medicines to emerging markets faster and aligning regulatory requirements across health agencies, such Health Canada and ANVISA has catapulted. In this interactive plenary session, we will dive into international collaboration efforts with emphasis on the surge in ANVISA activities to be at the forefront of the emerging market. We have leading representatives from Health Canada, ANVISA (Agencia Nacional de Vigilancia Sanitara) and USP (United States Pharmacopoeia) involved in International Collaborative initiatives to provide overview of collaborative work efforts, their challenges and a vision of the direction of these initiatives. The session will begin with presentations from several perspectives: Health Canada and its international collaboration programs; ANVISA and their growth in international partnerships; and USP’s pharmacopeial harmonization efforts. Following these overviews, attendees will have the opportunity to engage in an interactive discussion with the session moderator and speakers.

Learning Objective :
  • Explain the various international collaboration initiatives enabling access to quality medicine from Health Canada, ANVISA and USP
  • Share perspectives on real and perceived barriers to international collaborative initiatives
  • Illustrate successes and challenges with building converging practices and establishing a pathway for information-sharing initiatives
  • Gain a global perspective of new collaborative efforts and understanding of future directions

Speaker(s)

Maxime  Sasseville, PhD, MSc

Health Canada and International Collaboration Initiatives

Maxime Sasseville, PhD, MSc

Health Canada, Canada

Manager

Patricia  Oliveira Pereira Tagliari, LLM, MPH

ANVISA and International Collaboration Initiatives

Patricia Oliveira Pereira Tagliari, LLM, MPH

ANVISA, Brazil

Associate Director of the Second Directorate

Christopher  Colwell, MPA

USP: Collaborating to Expand the Supply of Quality Medicines Around the World

Christopher Colwell, MPA

US Pharmacopeia, United States

Vice President, International Government and Regulatory Affairs

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.